Table 2.
Serial number | Mature miRNA GSYM | P‐Valuea | Fold change | Chromosomal location |
---|---|---|---|---|
MicroRNAS with higher expression in hematoma enlargement cases | ||||
1 | hsa‐miR‐522 | 0.007 | 2.491 | Chromosome 19; NC_000019.9 |
2 | hsa‐miR‐1290 | 0.004 | 2.453 | Chromosome 1; NC_000001.10 |
3 | hsa‐miR‐586 | 0.008 | 2.000 | Chromosome 6; NC_000006.11 |
4 | hsa‐miR‐29c | 0.010 | 1.966 | Chromosome 1; NC_000001.10 |
5 | hsa‐miR‐100b | 0.016 | 1.955 | Chromosome 11; NC_000011.9 |
6 | hsa‐miR‐130ab | 0.007 | 1.895 | Chromosome 11; NC_000011.9 |
7 | hsa‐let‐7f‐2b | 0.008 | 1.895 | Chromosome X; NC_000023.10 |
8 | hsa‐miR‐574‐5p | 0.002 | 1.839 | Chromosome 4; NC_000004.11 |
9 | hsa‐miR‐29b‐1b | 0.016 | 1.781 | Chromosome 7; NC_000007.13 |
10 | hsa‐miR‐122 | 0.008 | 1.764 | Chromosome 18; NC_000018.9 |
11 | hsa‐miR‐19ab | 0.022 | 1.739 | Chromosome 13; NC_000013.10 |
12 | hsa‐miR‐29b | 0.023 | 1.726 | Chromosome 7; NC_000007.13 |
13 | hsa‐miR‐545b | 0.029 | 1.722 | Chromosome X; NC_000023.10 |
14 | hsa‐miR‐186b | 0.026 | 1.664 | Chromosome 1; NC_000001.10 |
15 | hsa‐miR‐518c | 0.041 | 1.635 | Chromosome 19; NC_000019.9 |
16 | hsa‐miR‐22 | 0.042 | 1.573 | Chromosome 17; NC_000017.10 |
17 | hsa‐miR‐542‐3p | 0.045 | 1.545 | Chromosome X; NC_000023.10 |
18 | hsa‐miR‐369‐3p | 0.033 | 1.516 | Chromosome 14; NC_000014.8 |
19 | hsa‐miR‐1294 | 0.042 | 1.432 | Chromosome 5; NC_000005.9 |
MicroRNAS with lower expression in hematoma enlargement cases | ||||
20 | hsa‐miR‐211 | 0.043 | 0.641 | Chromosome 15; NC_000015.9 |
21 | hsa‐miR‐365 | 0.039 | 0.626 | Chromosome 16; NC_000016.9 |
22 | hsa‐miR‐598 | 0.046 | 0.622 | Chromosome 8; NC_000008.10 |
23 | hsa‐miR‐325 | 0.049 | 0.621 | Chromosome X; NC_000023.10 |
24 | hsa‐miR‐454b | 0.031 | 0.612 | Chromosome 17; NC_000017.10 |
25 | hsa‐miR‐573 | 0.047 | 0.587 | Chromosome 4; NC_000004.11 |
26 | hsa‐miR‐1265 | 0.013 | 0.577 | Chromosome 10; NC_000010.10 |
27 | hsa‐miR‐105b | 0.036 | 0.551 | Chromosome X; NC_000023.10 |
28 | hsa‐miR‐1225‐5p | 0.046 | 0.524 | Chromosome 16; NC_000016.9 |
29 | hsa‐miR‐1202 | 0.007 | 0.474 | Chromosome 6; NC_000006.11 |
30 | hsa‐miR‐1249 | 0.002 | 0.401 | Chromosome 22; NC_000022.10 |
P‐values reported are the result of comparison analysis of microRNA expression levels from 32(14/18) ICH patients with or without HE.
In the miRNA cloning study, investigators found that the same precursor could be transcripted from 5′ or 3′ respectively and generated two miRNA molecules. If the cloning research can determine the relative expression levels of the two molecules, a * sign was used to represent the secondary expression quantity molecule.